These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2933470)

  • 1. The in vitro effect of retinol on human gingival epithelium. II. Modulation of Langerhans cell markers and interleukin-1 production.
    Walsh LJ; Seymour GJ; Powell RN
    J Invest Dermatol; 1985 Dec; 85(6):501-6. PubMed ID: 2933470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of HLA-DR antigens in the gingival epithelium in vitro by heat-killed Fusobacterium nucleatum and E. coli lipopolysaccharide.
    Walsh LJ; Seymour GJ; Bird PS; Powell RN
    J Oral Pathol; 1985 Nov; 14(10):833-43. PubMed ID: 2414424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of gingival Langerhans cell T6 antigen expression in vitro by interleukin 1 and an interleukin 1 inhibitor.
    Walsh LJ; Seymour GJ; Powell RN
    Clin Exp Immunol; 1986 May; 64(2):334-41. PubMed ID: 3091301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of Langerhans cells from gingival tissue maintained in organ culture.
    Walsh LJ; Powell RN; Seymour GJ; Newcomb GM
    J Oral Pathol; 1984 Dec; 13(6):604-13. PubMed ID: 6151591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical analysis of effects of cyclosporin A on gingival epithelium.
    Niimi A; Tohnai I; Kaneda T; Takeuchi M; Nagura H
    J Oral Pathol Med; 1990 Oct; 19(9):397-403. PubMed ID: 1702835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of class II (DR and DQ) antigen expression on gingival Langerhans cells in vitro by gamma interferon and prostaglandin E2.
    Walsh LJ; Seymour GJ; Powell RN
    J Oral Pathol; 1986 Jul; 15(6):347-51. PubMed ID: 3093653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human gingival Langerhans cells stimulate allogeneic lymphocytes: requirement for MHC class II antigens.
    Walsh LJ; Seymour GJ; Powell RN
    J Periodontol; 1990 Jun; 61(6):328-33. PubMed ID: 2366140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro modulation of T6 expression on gingival Langerhans cells by interleukin-1 inhibitors and ETAF.
    Walsh LJ; Lander PE; Seymour GJ; Powell RN
    J Dent Res; 1987 Mar; 66(3):766-9. PubMed ID: 3112200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of allogeneic T-cell activating ability and Langerhans cell markers in human epidermal cell cultures.
    Demidem A; Faure M; Dezutter-Dambuyant C; Thivolet J
    Clin Immunol Immunopathol; 1986 Mar; 38(3):319-26. PubMed ID: 2935342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral mucosal Langerhans cells express DR and DQ antigens.
    Walsh LJ; Seymour GJ; Savage NW
    J Dent Res; 1986 Mar; 65(3):390-3. PubMed ID: 3457041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The regulation of Langerhans cell T6, DR and DQ antigen expression: an hypothesis.
    Walsh LJ; Seymour GJ; Powell RN
    J Oral Pathol; 1988 Jan; 17(1):43-6. PubMed ID: 3131509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of Class II (DR & DQ) antigens by human gingival Langerhans' cells and keratinocytes in vitro.
    Walsh LJ; Seymour GJ; Powell RN
    J Oral Pathol; 1987 Jan; 16(1):27-30. PubMed ID: 2435875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of CD4 antigen expression on human gingival Langerhans cells by gamma interferon.
    Walsh LJ; Parry A; Scholes A; Seymour GJ
    Clin Exp Immunol; 1987 Nov; 70(2):379-85. PubMed ID: 3123106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-10 inhibits the primary allogeneic T cell response to human epidermal Langerhans cells.
    Péguet-Navarro J; Moulon C; Caux C; Dalbiez-Gauthier C; Banchereau J; Schmitt D
    Eur J Immunol; 1994 Apr; 24(4):884-91. PubMed ID: 8149959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OKT6 is not superior to HLA-DR or ATPase as a marker for Langerhans' cells in normal human epidermis.
    Liu HH; Schroeter AL; Muller SA
    Clin Exp Dermatol; 1986 May; 11(3):229-37. PubMed ID: 2943537
    [No Abstract]   [Full Text] [Related]  

  • 16. Langerhans cell dynamics in human gingiva during experimentally induced inflammation.
    Moughal NA; Adonogianaki E; Kinane DF
    J Biol Buccale; 1992 Sep; 20(3):163-7. PubMed ID: 1283608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinoic acid upregulates human Langerhans cell antigen presentation and surface expression of HLA-DR and CD11c, a beta 2 integrin critically involved in T-cell activation.
    Meunier L; Bohjanen K; Voorhees JJ; Cooper KD
    J Invest Dermatol; 1994 Dec; 103(6):775-9. PubMed ID: 7798614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human epidermal Langerhans cells and peripheral blood monocytes. Accessory cell function, autoactivating and alloactivating capacity and ETAF/IL-1 production.
    Räsänen L; Lehto M; Jansén C; Reunala T; Leinikki P
    Scand J Immunol; 1986 Nov; 24(5):503-8. PubMed ID: 3491421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of X-irradiation on epidermal immune function: decreased density and alloantigen-presenting capacity of Ia+ Langerhans cells and impaired production of epidermal cell-derived thymocyte activating factor (ETAF).
    Breathnach SM; Katz SI
    J Invest Dermatol; 1985 Dec; 85(6):553-8. PubMed ID: 3877770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ontogeny of Langerhans cells in human embryonic and fetal skin: expression of HLA-DR and OKT-6 determinants.
    Foster CA; Holbrook KA; Farr AG
    J Invest Dermatol; 1986 Mar; 86(3):240-3. PubMed ID: 2427603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.